Details for New Drug Application (NDA): 017464

NDA 017464 describes SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, which is a drug marketed by B Braun, Fresenius Kabi Usa, Fresenius Medcl, Haemonetics, Hospira, Icu Medical Inc, Laboratorios Grifols, Liebel-flarsheim, Abbott, Baxter Hlthcare, Jubilant Cadista, Miles, Nephron, and Taro, and is included in twenty-seven NDAs. It is available from twenty-one suppliers. Additional details are available on the SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER profile page.

The generic ingredient in SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is sodium chloride. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the sodium chloride profile page.

Summary for 017464

Tradename:	SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Applicant:	B Braun
Ingredient:	sodium chloride
Patents:	0

Pharmacology for NDA: 017464

Mechanism of Action	Osmotic Activity
Physiological Effect	Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption

Suppliers and Packaging for NDA: 017464

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	sodium chloride	INJECTABLE;INJECTION	017464	NDA	B. Braun Medical Inc.	0264-1800	0264-1800-31	84 CONTAINER in 1 CASE (0264-1800-31) / 50 mL in 1 CONTAINER
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	sodium chloride	INJECTABLE;INJECTION	017464	NDA	B. Braun Medical Inc.	0264-1800	0264-1800-32	64 CONTAINER in 1 CASE (0264-1800-32) / 100 mL in 1 CONTAINER

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	900MG/100ML
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AP	RLD:	Yes

Complete Access Available with Subscription